Sanara MedTech
SMTI
43 hedge funds and large institutions have $25.1M invested in Sanara MedTech in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 4 closing their positions.
0.26% less ownership
Funds ownership: 8.14% → 7.88% (-0.26%)
9% less funds holding
Funds holding: 47 → 43 (-4)
12% less capital invested
Capital invested by funds: $28.6M → $25.1M (-$3.45M)
38% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 21
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$311K |
| 2 |
Renaissance Technologies
New York
|
+$183K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$172K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$163K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$16.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$467K |
| 2 |
BlackRock
New York
|
-$268K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$149K |
| 4 |
Barclays
London,
United Kingdom
|
-$98.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$96.2K |
SMTI Hedge Fund Activity: Q1 2024 in Review
43 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q1 2024, worth a combined $25.1M — down 12% from $28.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of SMTI and 1 opened new positions — a net loss of 3 holders — while 21 trimmed existing stakes and 13 added.
The largest buyer was Royal Bank of Canada, adding an estimated $311K. The largest seller was Morgan Stanley, cutting an estimated $467K.
- 43 institutional investors held Sanara MedTech (SMTI) as of Q1 2024, down from 47 in Q4 2023.
- Funds reported $25.1M of Sanara MedTech stock for Q1 2024, down 12% quarter-over-quarter.
- 1 fund opened new Sanara MedTech positions in Q1 2024 and 4 closed out, a net change of -3 holders.
- The largest Sanara MedTech buyer in Q1 2024 was Royal Bank of Canada, an estimated $311K added.
- The largest Sanara MedTech seller in Q1 2024 was Morgan Stanley, an estimated $467K sold.
Based on aggregated 13F filings for Q1 2024.